The Use of Parenteral Iron Formulations in Anemia in Patients with Chronic Kidney Diseas

Authors

  • Ya.A. Dombrovskyi Department of Nephrology and Renal Replacement Therapy of the National Medical Academy of Postgraduate Education named after P.L. Shupik, Kyiv Clinical Hospital № 18, Kyiv, Ukraine
  • D.D. Ivanov Department of Nephrology and Renal Replacement Therapy of the National Medical Academy of Postgraduate Education named after P.L. Shupik, Kyiv Clinical Hospital № 18, Kyiv, Ukraine http://orcid.org/0000-0003-2609-0051

DOI:

https://doi.org/10.22141/2307-1257.0.4.14.2015.74901

Abstract

Iron preparations- an obligatory element of the complex therapyof anemiain patients withchronic kidney diseaseaccording to international recommendations.When choosing aoral and parenteralformsin most casesin practice, preference is given topreparationsfor intravenous use, Fe saharatis.

Downloads

Download data is not yet available.

References

Пыриг Л.А., Иванов Д.Д. Нефрология: Национальный учебник. — Донецк, 2014. — С. 251-268.

Drawz P., Rahman M. In the clinic Chronic kidney disease // Ann. Intern. Med. — 2009. — 150. — ITC2-1-15: quiz ITC12-16.

Astor B.C., Muntner P., Levin A., Eustace J.A., Coresh J. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988–1994) // Arch. Intern. Med. — 2002. — 162. — 1401-1408.

Ермоленко В.М., Николаев А.Ю. Эритропоэтин: биологические свойства и применение в клинике // Тер. арх. — 1990. — 62(11). — 141-145.

Bauer С. Erythropoietin — from gene structure to therapeutic applications // J. Perinat. Med. — 1995. — 23. — 77-81.

Holland D.C., Lam M. Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study // Nephrol. Dial. Transplant. — 2000. — 15. — 650-658.

Levin A., Djurdjev O., Duncan J., Rosenbaum D., Werb R. Haemoglobin at time of referral prior to dialysis predicts survival: An association of haemoglobin with long-term outcomes // Nephrol. Dial. Transplant. — 2006. — 21. — 370-377.

Klang B., Bjorvell H., Clyne N. Quality of life in predialytic uremic patients // Qual. Life Res. — 1996. — 5. — 109-116.

Teehan B.P., Benz R.L., Sigler M.H., Brown J.M. Early intervention with recombinant human erythropoietin therapy // Semin. Nephrol. — 1990. — 10. — 28-34.

KDIGO (2012) // Kidney International Supplements. — 2012. — 2. — 281; doi:10.1038/kisup.2012.39.

Kidney Disease: Improving Global Outcomes guidelines on anaemiz management in chronic kidney disease: a European Renal Best Practoce position statement // Nephrol. Dial. Transplant. — 2013. — Vol. 28, № 6. — 1346-1359.

Anaemia management in people with chronic kidney disease // National Clinical Guideline Centre. Anaemia management in people with chronic kidney disease. — London (UK): National Institute for Health and Care Excellence (NICE). — 2015, Jun 3. — 43 p. (NICE guideline; no. 8).

European Parliament. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use // Official Journal L. — 2004. — 136 (47). — 3457.

Schellekens H., Klinger E., Mhlebach S. et al. The therapeutic equivalence of complex drugs // Regul. Toxicol. Pharmacol. — 2011. — 59. — 176-83.

Committee for Medicinal Products for Human Use, 2011. Reflection paper on nonclinical studies for generic nanoparticle iron medicinal product applications. EMA/CHMP/SWP/100094/2011.

Toblli J.E., Cao G., Oliveri L. et al. Differences between original intravenous iron sucrose and iron sucrose similar preparations // Drug Research. — 2009. — 59(4). — 176-90.

Toblli J.E., Cao G., Giani J. et al. Different effects of European iron sucrose similar preparations and originator iron sucrose on nitrosative stress, apoptosis, oxidative stress, biochemical and inflammatory markers in rats // XLVIII ERA EDTA Congress. — 2011. — SuO028.

Reid Kait. Is Iron Sucrose (Venofer) a Safe Treatment for People with Chronic Kidney Disease? // PCOM Physician Assistant Studies Student Scholarship. — 2011. — P. 17.

Rottembourg J., Kadri A., Leonard E. et al. Do two intravenous iron sucrose preparations have the same efficacy? // Nephrol. Dial. Transplant. — 2011. doi: 10.1093/ndt/gfr024.

McClellan W., Aronoff S.L., Bolton W.K., Hood S., Lor-ber D.L., Tang K.L., Tse T.F., Wasserman B., Leiserowitz M. The prevalence of anemia in patients with chronic kidney disease // Curr. Med. Res. Opin. — 2004. — 20. — 1501-1510.

Іванов Д.Д., Корж О.М. Нефрологія в практиці сімейного лікаря: Навчально-методичний посібник. — 2-ге вид., переробл. — Донецьк: Видавець Заславський О.Ю., 2012. — С. 121-128.

Downloads

Published

2022-01-19

How to Cite

Dombrovskyi, Y., & Ivanov, D. (2022). The Use of Parenteral Iron Formulations in Anemia in Patients with Chronic Kidney Diseas. KIDNEYS, (4.14), 57–60. https://doi.org/10.22141/2307-1257.0.4.14.2015.74901

Issue

No. 4.14 (2015)

Section

To Help the Practitioner

License

Copyright (c) 2015 Ya.A. Dombrovskyi, D.D. Ivanov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.